Afya Ltd
AFYA Nasdaq· Services-Educational Services
Last close · Oct 23, 2026
$15.09
KIRA · Stoqly’s AI analyst, in plain words
- Afya Ltd had $661M of revenue in fiscal 2025, up 7.8% on the year before. Over five years, revenue changed +23.2% a year on average.
- Its operating margin was 32.8%, up 2.2 pts: of every 100 in sales, about 33 is left after running the business.
- Afya Ltd made $135M of net profit in fiscal 2025. From fiscal 2017 to 2025, diluted EPS grew 16.3% a year.
- Free cash flow was $244M in fiscal 2025, 36.9% of revenue.
- Afya Ltd returned $26.3M to shareholders in fiscal 2025, 11% of free cash flow. The diluted share count rose 0.1%.
- Afya Ltd owes $170M more than it holds in cash, about 0.6 years of operating profit.
Market cap
$1.4B
P/E
10.2x
Revenue
$661M
Net income
$135M
Free cash flow
$244M
Operating margin
32.8%
Afya Ltd in 30 seconds · fiscal 2025
Are sales growing?
+7.8%
Yes. Sales grew 7.8% last year.
Does it make a profit?
20.4%
Yes. It keeps 20.4% of every sale as profit.
Does profit turn into cash?
36.9%
Yes. 36.9% of sales ends up as free cash.
Is debt under control?
0.6x
Yes. It could repay its debt with 0.6 years of operating profit.
How healthy are the accounts?
6 / 9
Mixed. It passes 6 of 9 health tests.
How is the share priced?
10.2x
One share costs 10.2 times its yearly profit per share.
What Afya Ltd does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F · Mar 31, 2026
- Legal name
- Afya Ltd
- CIK
- 0001771007
Afya Ltd · AFYA
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $319M | $451M | $576M | $613M | $661M |
| Revenue growth | 36.8% | 41.4% | 27.7% | 6.5% | 7.8% |
| Gross margin | 62.1% | 63.1% | 61.4% | 63.2% | 64.5% |
| Operating margin | 25.6% | 28.5% | 26.7% | 30.6% | 32.8% |
| Net income | $41.4M | $72.3M | $77.3M | $117M | $135M |
| Net margin | 13.0% | 16.0% | 13.4% | 19.1% | 20.4% |
| Diluted EPS | $0.44 | $0.80 | $0.85 | $1.29 | $1.47 |
| Cash | |||||
| Cash from operations | $117M | $163M | $209M | $266M | $274M |
| Capital expenditure | $23.3M | $32.5M | $23.7M | $25.4M | $29.7M |
| Free cash flow | $93.6M | $131M | $185M | $240M | $244M |
| FCF margin | 29.4% | 29.0% | 32.2% | 39.2% | 36.9% |
| Dividends paid | $3.5M | $3.8M | $3.8M | $3.4M | $26.3M |
| Share count change | 0.5% | −3.7% | −0.1% | 0.7% | 0.1% |
| Debt and strength | |||||
| Cash and short-term investments | $134M | $207M | $114M | $147M | $205M |
| Debt incl. finance leases | $247M | $356M | $371M | $355M | $375M |
| Shareholders' equity | $529M | $605M | $742M | $690M | $886M |
| Net debt / EBITDA | 1.0x | 0.9x | 1.2x | 0.8x | 0.6x |
| Current ratio | 1.6x | 1.8x | 1.1x | 1.4x | 2.2x |
| Interest coverage | 1.8x | 1.9x | 1.7x | 2.2x | 2.2x |
| Returns and quality | |||||
| Return on capital | 11.3% | 15.6% | 14.5% | 20.1% | 16.2% |
| Return on equity | 7.8% | 12.7% | 11.5% | 16.4% | 17.1% |
| Piotroski F-score | 4 | 8 | 6 | 7 | 6 |
| Altman Z'' | 2.1 | 2.6 | 2.3 | 3.0 | 3.7 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$3.3M
6 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Afya Ltd · AFYA
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $15.09 a share, the company is worth $1.4B: 10.2 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0001771007). Data updated October 24, 2026. Filed in BRL under IFRS and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. For information only — not investment advice. Check the original filings before relying on any figure.